Glanbia Plc ADR (
OTCMKTS:GLAPY -
Get Free Report) was the target of a large decline in short interest in August. As of August 31st, there was short interest totaling 100 shares, a decline of 50.0% from the August 15th total of 200 shares. Currently, 0.0% of the company's stock are short sold. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 1.0 days. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.0% of the company's stock are short sold.
Glanbia Trading Down 1.5%
GLAPY traded down $1.21 on Friday, hitting $79.41. The company had a trading volume of 105 shares, compared to its average volume of 16. The company's fifty day moving average price is $75.71 and its 200 day moving average price is $69.72. Glanbia has a 1-year low of $52.40 and a 1-year high of $83.00. The company has a quick ratio of 0.81, a current ratio of 1.67 and a debt-to-equity ratio of 0.41.
Glanbia Cuts Dividend
The business also recently announced a dividend, which will be paid on Tuesday, October 14th. Investors of record on Tuesday, August 26th will be issued a $0.9751 dividend. This represents a yield of 272.0%. The ex-dividend date is Monday, August 25th.
Glanbia Company Profile
(
Get Free Report)
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Glanbia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.
While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.